Construction and application of a liver disease refined management platform based on hepatocellular carcinoma screening
10.3969/j.issn.1671-332X.2025.05.028
- VernacularTitle:基于肝癌筛查的肝病精细化管理平台建设与应用研究
- Author:
Minhui SHAO
1
;
Jingjuan DAI
1
;
Shengdong WU
1
;
Bin XIA
1
Author Information
1. 宁波市医疗中心李惠利医院 浙江宁波 315000
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma screening;
Refined management of liver disease;
Risk stratification;
Patient fol-low-up management;
MDT discussions
- From:
Modern Hospital
2025;25(5):767-771
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish a liver disease refined management platform encompassing hepatocellular carcinoma(HCC)screening for high-risk populations,longitudinal patient follow-up management,multidisciplinary team(MDT)consulta-tions for complex cases,and intelligent data analysis.This platform aims to achieve early detection and standardized management of individuals at risk of HCC,thereby improving the rates of curative treatment and patient survival.Methods Standardized data interfaces were utilized to integrate diverse medical data,including electronic health records,laboratory test results,and imaging reports.Multiple HCC risk assessment models were applied to assist clinicians in patient risk stratification and diagnosis.For un-diagnosed patients,personalized follow-up programs were implemented according to their risk categories.Clinical information of patients requiring MDT discussions was systematically collated to support comprehensive case evaluations.Results After the platform's introduction,a total of 6 187 patients were enrolled,accounting for 23.2％of outpatient attendees.The number of MDT discussions reached 351,representing a 46.3％year-on-year increase.The outcomes demonstrated significant improvements in the quality of liver disease management and diagnostic processes.Conclusion The platform can effectively achieve precise stratification of HCC risk groups,providing significant support for the early detection,diagnosis,and treatment of high-risk indi-viduals.Additionally,it offers a digital solution for facilitating the full-cycle precision management of liver disease patients,from screening to diagnosis treatment and follow-up.
